MSKCC updates recommendations on risk-based prostate cancer screening

In an article currently in press in Urology (“the Gold journal”) researchers and clinicians at the Memorial Sloan-Kettering Cancer Center have provided a detailed 2016 update to the MSKCC guidelines on the use of the PSA test in assessment of risk for prostate cancer. … READ MORE …

More from the EAU annual meeting in Munich

UroToday has provided a second set of reports on the key presentations given at the annual meeting of the European Association of Urology, being held this year in Munich, Germany. … READ MORE …

What’s happening at the annual EAU meeting in Munich?

So our friends at UroToday have started providing reports on the key presentations that are being given at the annual meeting of the European Association of Urology, being held this year in Munich, Germany. Here are links to some interesting reports … READ MORE …

Will we ever be able to prove the value of screening for prostate cancer?

The results of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), which have been published today in The Lancet, offer us some interesting insights into whether we will ever, actually, be able to prove that screening men for risk of prostate cancer reduces the risk of prostate cancer-specific death. … READ MORE …

CMS appears to walk away from anti-PSA screening initiative

On November 15 last year we advised our readers that CMS had initiated an ill-advised process to “discourage the use of PSA-based screening” for prostate cancer. … READ MORE …

Controversy is often driven by presumption and perception

A new article in JAMA Internal Medicine this week is likely to keep the fires burning under the PSA screening controversy for quite a while to come. … READ MORE …

A highly qualified “thank you” to Drs. Welch and Albertsen — maybe?

The prostate cancer patient community should be aware of an “op-ed” in today’s New York Times by Drs. Gilbert Welch and Peter Albertsen arguing that Medicare should continue to let individual physicians make their own decisions about the use of the PSA test for risk of prostate cancer. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,454 other followers